A clinical trial to study the role of MRI, gray scale and colour Doppler ultrasound in evaluating how patients with breast cancer respond to chemotherapy given before surgery
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Breast cancer
- Registration Number
- CTRI/2018/02/011851
- Lead Sponsor
- Dr Rajinder Parshad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
1. Single palpable breast mass before chemotherapy
2. Histologically proven case of breast cancer
3. Patients with locally advanced breast cancer (T3/ T4 with any nodal status)
4. Age of the patient 18 - 65 years
5. Those who give informed written consent for the study
Exclusion Criteria
1. Patients who got <2 cycles of neoadjuvant chemotherapy
2. Patients who completed 3 cycles of chemotherapy but not operated
3. Patients lost to follow up or expired during or after NACT
4. Patients with distant metastasis and recurrent breast cancer
5. Patient not fit for neoadjuvant chemotherapy or MRI
6. Multicentric or multifocal breast cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method